Making sense of the debate over AI psychosis

The term 'AI psychosis' is making rounds in tech circles, and it's worth understanding what people mean by it. The latest Equity podcast episode dives into whether tech CEOs are particularly vulnerable to losing perspective on AI capabilities and limitations.

The core question is simple. Do founders and executives in the AI space have a harder time staying grounded about what their technology can actually do? When you're building AI products or running an AI company, the line between visionary thinking and detachment from reality can get blurry.

This matters because these leaders shape product roadmaps, set investor expectations, and influence how millions of people think about AI capabilities. If the people steering AI development have an distorted view of what's possible or imminent, that affects everything from product quality to market stability.

For professionals using AI tools, this debate has practical implications. It helps explain why some AI products overpromise and underdeliver. It's a reminder to evaluate AI tools based on what they actually do today, not what their creators say they'll do tomorrow.

The discussion also touches on a broader pattern in tech. Founders often need to be optimistic to the point of delusion to build something new. But with AI, where capabilities are genuinely hard to assess and changing rapidly, that optimism can cross into territory that misleads users, investors, and the public.

Whether you call it psychosis, hype, or founder vision gone too far, the phenomenon is real enough to warrant attention. Stay skeptical, test claims against reality, and remember that even brilliant technologists can lose perspective on their own creations.